LGALS3 and congenital heart disease: Considering the results in adults with congenital heart disease, there is an optimistic view for galectin-3 to serve as a valuable marker, especially for the prediction of life-threatening arrhythmias, and hopefully for ventricular function assessment and risk stratification in specific groups of patients.